Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 2
2003 3
2004 3
2005 3
2006 5
2007 3
2008 5
2009 3
2010 1
2011 1
2012 2
2013 2
2014 2
2015 7
2016 13
2017 11
2018 4
2019 9
2020 16
2021 13
2022 8
2023 11
2024 15
2025 16

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

138 results

Results by year

Filters applied: . Clear all
Page 1
Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer.
Uppaluri R, Haddad RI, Tao Y, Le Tourneau C, Lee NY, Westra W, Chernock R, Tahara M, Harrington KJ, Klochikhin AL, Braña I, Vasconcelos Alves G, Hughes BGM, Oliva M, Pinto Figueiredo Lima I, Ueda T, Rutkowski T, Schroeder U, Mauz PS, Fuereder T, Laban S, Oridate N, Popovtzer A, Mach N, Korobko Y, Costa DA, Hooda-Nehra A, Rodriguez CP, Bell RB, Manschot C, Benjamin K, Gumuscu B, Adkins D; KEYNOTE-689 Investigators. Uppaluri R, et al. Among authors: popovtzer a. N Engl J Med. 2025 Jul 3;393(1):37-50. doi: 10.1056/NEJMoa2415434. Epub 2025 Jun 18. N Engl J Med. 2025. PMID: 40532178 Clinical Trial.
[Subglottic carcinoma].
Bahar G, Nageris BI, Spitzer T, Popovtzer A, Mharshak G, Feinmesser R. Bahar G, et al. Among authors: popovtzer a. Harefuah. 2002 Oct;141(10):914-8, 929. Harefuah. 2002. PMID: 12420600 Review. Hebrew.
Phase I and II Clinical Studies of the STING Agonist Ulevostinag with and without Pembrolizumab in Participants with Advanced or Metastatic Solid Tumors or Lymphomas.
Harrington KJ, Champiat S, Brody JD, Cho BC, Romano E, Golan T, Hyngstrom JR, Strauss J, Oh DY, Popovtzer A, Gomez-Roca C, Perets R, Kim SB, Wong DJ, Powell SF, Khilnani A, Jemielita T, Zhao Q, Zhao R, Ingham M. Harrington KJ, et al. Among authors: popovtzer a. Clin Cancer Res. 2025 Aug 14;31(16):3400-3411. doi: 10.1158/1078-0432.CCR-24-3630. Clin Cancer Res. 2025. PMID: 40499147 Clinical Trial.
Commissioning of a novel gantry-less proton therapy system.
Feldman J, Pryanichnikov A, Achkienasi A, Polyansky I, Hillman Y, Raskin S, Blumenfeld P, Popovtzer A, Marash M. Feldman J, et al. Among authors: popovtzer a. Front Oncol. 2024 Nov 7;14:1417393. doi: 10.3389/fonc.2024.1417393. eCollection 2024. Front Oncol. 2024. PMID: 39575421 Free PMC article.
Cetuximab intensifies cisplatin-induced testicular toxicity.
Levi M, Popovtzer A, Tzabari M, Mizrachi A, Savion N, Stemmer SM, Shalgi R, Ben-Aharon I. Levi M, et al. Among authors: popovtzer a. Reprod Biomed Online. 2016 Jul;33(1):102-10. doi: 10.1016/j.rbmo.2016.04.004. Epub 2016 Apr 20. Reprod Biomed Online. 2016. PMID: 27184186
138 results